Roger S. McIntyre, MD

Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

JCP
Distinguishing Bipolar Disorder From MDD: Points to Remember
Insights

April 13, 2021

Dr Roger S. McIntyre highlights 3 important considerations in the differential diagnosis of bipolar disorder and major depressive disorder: age at onset, episode recurrence, and delayed emergence of mania
JCP
Original Research

February 23, 2021

Even given known risk factors for suicide, predicting suicide is difficult. This study used deep learning of structural magnetic resonance imaging to create an algorithm for detecting suicidal ideation...
, , , et al
PCC
Original Research

September 17, 2020

Bipolar disorder is characterized by a chronic and subtle course of fluctuating symptoms. To explore the efficacy of cariprazine across the symptoms of bipolar depression, post hoc analyses of...
, , , et al
JCP
Correction

April 22, 2020

, , , et al
JCP
Letter to the Editor

January 28, 2020

 Rosenblat and McIntyre reply to the letter "Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?" by Swainson and Khullar.
,
JCP
Consensus Statement

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
, , , et al
JCP
Original Research

May 14, 2019

Find out in this population-based NHIRD study which treatments used for psoriasis can also stave off dementia, another inflammatory disease, and whether the type of dementia is a key...
, , , et al
JCP
The Differential Diagnosis of MDD Versus BP
Academic Highlights

May 14, 2019

Given the similarity in clinical presentation between major depressive disorder (MDD) and the depressive episodes of bipolar disorder (BP), misdiagnoses occur too often. Read this Academic Highlights to learn...
, , , et al
JCP
Review Article

April 16, 2019

Intravenous ketamine has rapid and robust antidepressant effects. Read this systematic review to learn if oral ketamine also has efficacy and tolerability in depressed individuals.
, , , et al
JCP
Educational Activity

February 20, 2019

Despite the availability of effective treatments for MDD, many individuals have difficulty achieving remission. Residual symptoms can be difficult to differentiate from treatment side effects. Through 2 comic-based case...
PCC
Article

November 1, 2018

What patient-reported factors influence medication treatment decisions among individuals with bipolar and unipolar depression? The authors of this article conducted a survey to answer this question. Their findings may...
, , , et al
JCP
Review Article

May 1, 2018

A variety of pharmacologic agents are available for treating your patients with bipolar disorder, but have you considered adding psychoeducation to your armamentarium? This review summarizes the evidence on...
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe